CymitQuimica logo

CAS 331253-86-2

:

PDK1/Akt/Flt Dual Pathway Inhibitor

Description:
PDK1/Akt/Flt Dual Pathway Inhibitor, with the CAS number 331253-86-2, is a synthetic compound designed to inhibit specific signaling pathways involved in cell growth and survival, particularly the PDK1/Akt and Flt pathways. This compound is primarily studied for its potential therapeutic applications in cancer treatment, as these pathways are often dysregulated in various malignancies. The inhibitor functions by blocking the activity of PDK1, which is a key regulator of the Akt signaling pathway, thereby impeding cell proliferation and promoting apoptosis in cancer cells. Additionally, it targets the Flt receptor, which is involved in angiogenesis, further contributing to its anti-tumor effects. The compound is characterized by its selective inhibition, which aims to minimize off-target effects and enhance therapeutic efficacy. Its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion, are crucial for determining its suitability for clinical use. Ongoing research continues to explore its efficacy and safety profile in preclinical and clinical settings.
Formula:C10H4N6O
Synonyms:
  • KP372-1(PDK1/Akt/Flt Dual Inhibitor)
  • PDK1/Akt inhibitor
  • KP 23172,KP23172
  • PDK1/Akt/Flt Dual Pathway Inhibitor
  • KP-23172
  • DPANHMGWPXVBQI-UHFFFAOYSA-N
Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.
  • PDK1/Akt/FltDualPathwayInhibitor

    CAS:
    Formula:C10H4N6O
    Purity:98%
    Molecular weight:224.1784

    Ref: IN-DA01E46F

    1mg
    198.00€
  • KP-23172

    CAS:
    KP-23172 is a inhibitor of PI3-K/Akt pathway.
    Formula:C10H4N6O
    Purity:98%
    Color and Shape:Solid
    Molecular weight:224.18

    Ref: TM-T12397

    25mg
    1,444.00€
    50mg
    1,882.00€
    100mg
    2,375.00€
  • PDK1/Akt/Flt Dual Pathway Inhibitor

    CAS:

    PDK1/Akt/Flt Dual Pathway Inhibitor is a drug that inhibits the activity of diacylglycerol, a lipid molecule that can be produced by the cells when they are stimulated by growth factors. PDK1/Akt/Flt Dual Pathway Inhibitor binds to the receptor for tnf-α and blocks its binding site on the surface of cells, thereby preventing activation of the protein. This drug has been shown to reduce tumor size in animals with cancer and has been shown to enhance the effectiveness of other drugs used in cancer treatment. PDK1/Akt/Flt Dual Pathway Inhibitor also has been shown to cause thrombocytopenia in humans.

    Formula:C10H4N6O
    Purity:Min. 95%
    Molecular weight:224.18 g/mol

    Ref: 3D-FP175579

    10mg
    Discontinued
    Discontinued product